You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 10,076,615


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,076,615
Title:Nasal delivery
Abstract: A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece for fitting to a nostril of a subject, wherein the nosepiece comprises a tip element which includes a delivery aperture from which substance is in use delivered into the nasal cavity, and the tip element is at least in part tapered such as to be inclined to a longitudinal axis of the nosepiece, with the delivery aperture extending both laterally across the tip element and along a longitudinal extent of the tip element; a nozzle through which substance is in use delivered, preferably substantially axially to a longitudinal axis of the nosepiece, to the respective nasal cavity; and a delivery unit for delivering substance through the nozzle of the nosepiece.
Inventor(s): Djupesland; Per Gisle (Oslo, NO), Sheldrake; Colin David (Wiltshire, GB)
Assignee: OptiNose AS (Oslo, NO)
Application Number:14/618,273
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,076,615

Introduction

United States Patent 10,076,615, titled "Nasal delivery device and method of delivering a substance to a nasal cavity," is a patent that outlines a specific innovation in the field of medical devices. To fully comprehend the implications and significance of this patent, it is crucial to delve into its scope, claims, and the broader patent landscape.

Patent Overview

The patent, assigned the number US10,076,615B2, was granted for a nasal delivery device and the method of using it to deliver substances to the nasal cavity of a subject. Here is a brief overview of the key components:

Device Components

  • Nosepiece: Designed to fit onto the nose, this component is integral for the proper administration of the substance.
  • Delivery Device: The overall apparatus that includes the nosepiece and other necessary parts for the delivery process[4].

Method of Delivery

The patent describes a method for delivering substances, such as medications or other therapeutic agents, directly into the nasal cavity. This method involves the use of the nasal delivery device to ensure precise and effective delivery.

Scope of the Patent

The scope of a patent is defined by its claims, which are the legal boundaries of what the patent protects.

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims and provide more specific details.

  • Independent Claims: These claims define the core elements of the invention, such as the nosepiece and the delivery mechanism.
  • Dependent Claims: These claims add additional features or limitations to the independent claims, such as specific materials used or additional components of the device[4].

Claim Analysis

To understand the patent's scope, analyzing the claims is essential.

Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Generally, narrower claims (those with fewer and more specific elements) are associated with a higher probability of grant and a shorter examination process[3].

  • Claim Specificity: The claims in US10,076,615B2 are specific enough to define the unique aspects of the nasal delivery device but broad enough to cover variations that do not stray from the core invention.
  • Claim Breadth: The breadth of the claims is crucial as it determines what is protected and what is not. In this case, the claims are broad enough to cover various applications of the nasal delivery device but narrow enough to avoid overly broad interpretations that could lead to invalidation[3].

Patent Landscape

The patent landscape surrounding US10,076,615B2 includes several key aspects:

Prior Art

Prior art refers to existing knowledge and inventions that predate the current patent. The patent office ensures that the claims do not overlap with prior art, making the invention novel and non-obvious.

  • Prior Art Keywords: Terms like "nosepiece," "nasal," "delivery device," and "delivery" indicate the areas where prior art was considered during the patent examination process[4].

Related Patents and Applications

The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding how US10,076,615B2 fits into the broader family of nasal delivery devices[1].

Legal and Regulatory Considerations

Patents must comply with various legal and regulatory requirements.

Patentability

The patent must meet the criteria for patentability as defined by Section 101 of the Patent Act, which includes being a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof. The Supreme Court has established tests, such as the "Alice test," to determine if claims are directed to patent-eligible subject matter[5].

  • Abstract Ideas: The claims must not be directed to abstract ideas, laws of nature, or natural phenomena. In the case of US10,076,615B2, the device and method are tangible and practical, thus avoiding these exceptions[5].

Practical Implications

Understanding the scope and claims of US10,076,615B2 has practical implications for several stakeholders:

Inventors and Manufacturers

For inventors and manufacturers, knowing the exact scope of the patent helps in avoiding infringement and in designing new products that do not infringe on existing patents.

Licensing and Litigation

The clarity of the claims affects licensing agreements and potential litigation. Narrower, well-defined claims reduce the likelihood of disputes and make it easier to negotiate licensing terms[3].

Future Developments

The patent landscape is dynamic, with continuous innovations and updates.

Patent Maintenance and Updates

Patents like US10,076,615B2 require maintenance payments to remain in force. The scope and claims may be updated or narrowed during the examination process or through subsequent amendments[3].

Conclusion

The United States Patent 10,076,615 is a significant innovation in the field of nasal delivery devices. Understanding its scope, claims, and the broader patent landscape is crucial for inventors, manufacturers, and legal professionals. Here are the key takeaways:

  • Specific Claims: The patent includes specific claims that define the unique aspects of the nasal delivery device.
  • Patent Scope: The scope is broad enough to cover various applications but narrow enough to avoid overly broad interpretations.
  • Legal Compliance: The patent complies with legal requirements, avoiding abstract ideas and other non-patentable subject matter.
  • Practical Implications: Clear claims help in avoiding infringement, facilitating licensing, and reducing litigation risks.

Key Takeaways

  • Clear Claims: The patent's claims are specific and well-defined.
  • Patent Scope: The scope is balanced between breadth and specificity.
  • Legal Compliance: The patent meets all legal requirements for patentability.
  • Practical Implications: Understanding the claims is crucial for inventors, manufacturers, and legal professionals.

FAQs

Q: What is the main invention described in US10,076,615B2? A: The main invention is a nasal delivery device and the method of delivering substances to the nasal cavity.

Q: How do the claims in US10,076,615B2 affect its scope? A: The claims define the specific elements of the invention, ensuring it is broad enough to cover various applications but narrow enough to avoid overly broad interpretations.

Q: What legal tests must the claims of US10,076,615B2 pass? A: The claims must pass tests such as the "Alice test" to ensure they are directed to patent-eligible subject matter.

Q: How does the Global Dossier service relate to US10,076,615B2? A: The Global Dossier service allows users to see related applications filed at participating IP Offices, helping to understand the broader patent family.

Q: What are the practical implications of understanding the scope and claims of US10,076,615B2? A: Understanding the scope and claims helps in avoiding infringement, facilitating licensing agreements, and reducing litigation risks.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - US10076615B2: https://patents.google.com/patent/US10076615B2/en
  5. CAFC - CONTOUR IP HOLDING LLC v. GOPRO, INC.: https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,076,615

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY ⤷  Subscribe
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE ⤷  Subscribe
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY ⤷  Subscribe
Optinose Us Inc XHANCE fluticasone propionate SPRAY, METERED;NASAL 209022-001 Sep 18, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,076,615

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0706863.8Apr 5, 2007

International Family Members for US Patent 10,076,615

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 2136865 ⤷  Subscribe
European Patent Office 2136865 ⤷  Subscribe
European Patent Office 3777939 ⤷  Subscribe
Spain 2829915 ⤷  Subscribe
Spain 2947933 ⤷  Subscribe
United Kingdom 0706863 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.